Hemiasterlin derivatives and uses thereof

Details for Australian Patent Application No. 2012200204 (hide)

Owner Eisai R&D Management Co., Ltd.

Inventors Kowalczyk, James J.; Schiller, Shawn; Seletsky, Boris M.; Spyvee, Mark; Yang, Hu; Campagna, Silvio A.; Fang, Francis G.

Agent Davies Collison Cave

Pub. Number AU-A-2012200204

Parent 2004276261

Filing date 13 January 2012

Wipo publication date 9 February 2012

International Classifications

C07K 1/06 (2006.01) General processes for the preparation of peptides

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/04 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

2 February 2012 Complete Application Filed

9 February 2012 Application Open to Public Inspection

  Published as AU-A-2012200204

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200205-A gaming system and a method of gaming

2012200203-Anti-CTLA-4 Antibody Compositions